Jamison Private Wealth Management, Inc. Caribou Biosciences, Inc. Transaction History
Jamison Private Wealth Management, Inc.
- $602 Billion
- Q2 2024
A detailed history of Jamison Private Wealth Management, Inc. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Jamison Private Wealth Management, Inc. holds 188 shares of CRBU stock, worth $351. This represents 0.0% of its overall portfolio holdings.
Number of Shares
188
Previous 188
-0.0%
Holding current value
$351
Previous $967,000
68.05%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRBU
# of Institutions
144Shares Held
53.7MCall Options Held
32.5KPut Options Held
89.8K-
Black Rock Inc. New York, NY6.95MShares$13 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$8.5 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.16MShares$7.78 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.08MShares$7.64 Million0.34% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.62MShares$4.91 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $114M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...